Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.100
+0.100 (5.00%)
At close: Jul 24, 2025

Bio-Works Technologies AB Company Description

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden.

It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins.

The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.

Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Bio-Works Technologies AB (publ)
CountrySweden
Founded2006
IndustryBiotechnology
SectorHealthcare
Employees30
CEOLone Carlbom

Contact Details

Address:
Virdings allé 18
Uppsala, 754 50
Sweden
Phone46 8 56 26 74 30
Websitebio-works.com

Stock Details

Ticker SymbolBIOWKS
ExchangeNordic Growth Market
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0007387089
SIC Code2833

Key Executives

NamePosition
Lone CarlbomChief Executive Officer
Jan BerglöfCo-Founder and Senior Advisor
Arne HaugeChief Financial Officer and Head of Support Functions
Helena PahlmSenior Director of Global Quality
Silvia HellstromHead of Quality Assurance
Maria ÅbergHead of Production
Anne DyrdalChief Commercial Officer